Endocrine University: Year-2 Fellows Program - Agenda

Endocrine University®: Disease Management for Endocrinology Fellows in Training

Mayo Clinic - Rochester, MN

November 7- 10, 2019

  • REGISTRATION – Thursday, November 7, 2019

  • 5:00 - 7:00 PM

    Registration

  • PROGRAM – Friday, November 8, 2019

  • 6:30 - 7:30 AM

    Breakfast and Exhibits

  • Rethinking Lipid Management to Reduce CVD: Statin Therapy & Beyond

    Moderator: Vinaya Simha, MD, MBBS
  • 7:30 - 8:00 AM

    Lipid Physiology and Pathogenesis of Monogenic Lipid Disorders

    Vinaya Simha, MD, MBBS
    Objectives:

    1. Appreciate the role of lipids in multiple physiological processes.
    2. Explain the basic principles of lipoprotein structure and function.
    3. Discuss the molecular basis of genetic disorders of lipid metabolism and transport.
  • 8:00 - 8:45 AM

    Landmark Lipid Trials and Current Lipid Treatment Guidelines

    Stephen Kopecky, MD
    Objectives:

    1. Briefly review major primary and secondary prevention trials of statin therapy.
    2. Review the evidence from non-statin trials to understand the role of combination lipid lowering therapy.
    3. Discuss the basis and limitations of different lipid treatment guidelines.
  • 8:45 - 9:30 AM

    Residual Risk and Novel Therapies

    Vinaya Simha, MD, MBBS
    Objectives:

    1. Appreciate the magnitude of residual cardiovascular risk after statin therapy.
    2. Discuss the basis for novel and emerging lipid lowering therapies.
    3. Review evidence for efficacy of novel therapies to understand their role in clinical practice.
  • 9:30 - 9:40 AM

    Question and Answer Session

    Vinaya Simha, MD, MBBS and Stephen Kopecky, MD

  • 9:40 - 10:00 AM

    Break and Exhibits

  • Obesity Medicine – An Interactive Session Utilizing the Audience Response System (ARS)

    Moderator: Daniel Hurley, MD, FACE
  • 10:00 - 10:50 AM

    Obesity Pathophysiology and AACE Obesity CPGs

    Daniel Hurley, MD, FACE

    Objectives:

    1. Discuss medical models of obesity management and rationale for a complications centric approach.
    2. Review the evidence demonstrating weight loss as an effective therapeutic tool to treat obesity-related complications.
  • 10:25 - 10:50 AM

    Lifestyle Management with Diet, Activity/Exercise, and Behavior Support

    Meera Shah, MB, ChB, MRCP
    Objectives:

    1. Review the principles of effective lifestyle intervention as a key role in obesity medicine.
    2. Discuss the impact of weight loss therapy regarding type-2 diabetes prevention.
  • 10:50 - 11:15 AM

    Medical Management of Obesity

    Meera Shah, MB, ChB, MRCP

    Objectives:

    1. Review the efficacy, safety, and role of medications in obesity management.
    2. Explain the impact of weight loss medical therapy in preventing type-2 diabetes.
  • 11:15 - 11:40 AM

    Surgical Management of Obesity

    Daniel Hurley, MD, FACE
    Objectives:

    1. Review the efficacy, safety, and role of bariatric surgery in obesity management
    2. Discuss the impact of bariatric weight loss therapy in the treatment of type-2 diabetes
  • 11:40 AM - Noon

    Question and Answer Session

    Meera Shah, MB, ChB, MRCP and Daniel Hurley, MD, FACE

  • Noon - 1:30 PM

    Lunch (no CME for this session)

    Welcoming Remarks

    Daniel Hurley, MD, FACE, Immediate Past-President, AACE

    Robert Wermers, Chair, Mayo Division of Endocrinology and Metabolism

    Thom W. Rooke, MD, FSVM, “Quest for Cortisone”

  • 1:30 - 2:45 PM

    Cushing Syndrome

    William F. Young, Jr., MD, MSc, FACE, FACP
    Objectives:

    1. Review the diagnostic approach to the patient with possible Cushing syndrome
    2. Describe the levels of diagnostic testing in evaluating a patient with Cushing syndrome
    3. Demonstrate the role for clinical and biochemical phenotypes in directing case-detection, subtype evaluation, and treatment for Cushing syndrome
  • 2:45 - 4:00 PM

    Pituitary Case Studies

    Susan L. Samson, MD, PhD, FRCPC, FACE
    Objectives:

    1. Review the anatomy and physiology of the pituitary gland.
    2. Discuss the causes of hyperprolactinemia and the indications for treatment.
    3. Describe a differential diagnosis of sellar masses.
  • 4:00 - 4:30 PM

    Break and Exhibits

  • 4:30 - 5:15 PM

    Growth Hormone Replacement: Not Just For Kids?

    Dana Erickson, MD, FACE
    Objectives:

    1. Describe the causes, symptoms and clinical consequences of growth hormone deficiency in adult patients.
    2. Identify the appropriate dynamic testing for the diagnosis of growth hormone deficiency in adults or patients transitioning from adolescence to adulthood.
    3. Integrate the current evidence of the risks and benefits of growth hormone therapy with patient specific characteristics to decide on initiation of growth hormone therapy.
  • 5:15 - 6:00 PM

    Diagnostic Evaluation of Pheochromocytoma

    William F. Young, Jr., MD, MSc, FACP, FACE
    Objectives:

    1. Review the diagnostic approach to the patient with possible pheochromocytoma.
    2. Demonstrate the various localization studies available to the endocrinologist.
    3. Discuss the role for genetic testing in the setting of paraganglioma or pheochromocytoma.
    4. Review follow-up strategies following resection of a pheochromocytoma.
  • 6:00 PM

    Adjourn

  • 6:30 - 8:00 PM

    Dinner - Who Wants to be a Millionaire Endocrinologist?

    William F. Young, Jr., MD, MSc, FACP, FACE

  • PROGRAM – Saturday, November 9, 2019

  • Endocrine Laboratory Testing and Reproductive Technologies

    Moderator: William F. Young, Jr., MD, FACP, FACE
  • 6:45 - 7:30 AM

    Breakfast and Exhibits

  • 7:30 - 8:30 AM

    Adrenal Insufficiency

    Irina Bancos, MD
    Objectives:

    1. Describe the etiology and presentation of adrenal insufficiency.
    2. Review the diagnostic approach to the patient with possible adrenal insufficiency.
    3. Discuss steroid replacement strategies.
  • 8:30 - 9:30 AM

    Invasive Dynamic Endocrine Testing

    William F. Young, Jr., MD, MSc, FACP, FACE
    Objectives:

    1. Review the endocrine disorders that may be subjected invasive dynamic endocrine testing.
    2. Summarize the key steps in performing and interpreting adrenal venous sampling and inferior petrosal sinus sampling
    3. List how to use invasive dynamic endocrine testing in endocrine practice.
  • 9:30 - 9:45 AM

    Break and Exhibits

  • 9:45 - 10:45 AM

    PCOS: Diagnostic Pearls and Management Strategies

    Rachel Pessah-Pollack, MD, FACE
    Objectives:

    1. Discuss diagnostic criteria and how to individualize test selection.
    2. Select among treatment options based on patient goals.
    3. Review how to screen and treat for co-morbidities of PCOS.
  • 10:45 - 11:45 AM

    Cutting Edge Reproductive Endocrinology

    Chandra C. Shenoy, MD
    Objectives:

    1. Review basic reproductive endocrinology testing for the evaluation of fertility problems.
    2. Discuss types of fertility treatment and their anticipated success rates.
    3. Identify the latest technological advancements for deferring reproduction.
  • Noon - 1:30 PM Lunch talk

    Transgender Health for Endocrinologists: A Case-Based Approach

    Vin Tangpricha, MD, PhD, FACE and Caroline Davidge-Pitts, MBBCh
    Objectives:

    1. Review definitions and terminology in transgender health.
    2. Discuss the reason and modalities for medical management of transgender people.
    3. Review cross hormone therapy and surgical techniques and discuss some challenges in management.
  • Bone Module

    Moderator: Robert A. Wermers, MD, FACE

  • 1:30 - 2:00 PM

    Clinical Approach to Metabolic Bone Disease

    Robert A. Wermers, MD, FACE
    Objectives:

    1. Describe a general clinical approach to metabolic bone diseases.
    2. Appreciate causes of high bone mass.
    3. Explain causes of low bone mass.
  • 2:00 - 3:30 PM

    Pharmacologic Approaches to Osteoporosis, Therapies and Cases

    Matthew Drake, MD, PhD

  • 3:30 - 4:00 PM

    Coffee Break

  • 4:00 - 4:45 PM

    Hypercalcemia and Hypocalcemia

    Robert A. Wermers, MD, FACE and Bart Clarke, MD
    Objectives:

    1. Review the causes, evaluation, and pitfalls in hypercalcemic disorders.
    2. Discuss the causes, evaluation, and treatment of hypocalcemia, including hypoparathyroidism.
  • 4:45 - 5:45 PM

    Renal Bone Disease and Kidney Transplant

    Daniel L. Hurley, MD, FACE and Robert A. Wermers, MD, FACE
    Objectives:

    1. Discuss the complexities of renal bone disease, including the assessment of bone volume, turnover, and mineralization.
    2. Review the limitations of current osteoporosis therapies in the treatment of osteoporosis in chronic kidney disease.
    3. Review the indications for bone biopsy in patients with renal bone disease.
    4. Recognize the value of bone histomorphometry in the assessment of bone disease in chronic kidney disease.
  • 5:45 - 6:00 PM

    Question and Answer Session

  • 7:00 - 9:00 PM

    Pizza Roundtable Discussions and Group Picture

  • PROGRAM – Sunday, November 10, 2019

  • The Essentials of Achieving a Successful and Rewarding Practice

  • 7:00 - 7:30 AM

    Breakfast

  • 7:30 - 8:15 AM

    Update in Diabetes

    Archana Sadhu, MD
    Objectives:

    1. Identify the most significant clinical and translational research advances that have been made in the last year in the fields of diabetes.
    2. Describe how the translational and clinical research data can be applied in the future to improve patient care in the clinic and hospital settings.
    3. Discuss the impact of the new discoveries on clinical practice.
  • 8:15 - 9:00 AM

    Update in Thyroid

    Juan P. Brito Campana, MBBS
    Objectives:

    1. Identify the most significant clinical and translational research advances that have been made in the last year in the fields of thyroid.
    2. Describe how the translational and clinical research data can be applied in the future to improve patient care in the clinic and hospital settings.
    3. Discuss the impact of the new discoveries on clinical practice.
  • 9:00 - 9:30 AM

    Breakfast

  • 9:30 - 11:30 AM

    The Business of Medicine

    W. Reid Litchfield, MD, FACE, ECNU; Jad Sfeir, MD; Sandra L. Weber, MD, FACP, FACE; S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE

  • 11:30 AM

    Endocrine University® Adjourns